Rinri Therapeutics is a private biotechnology company developing first-in-class cell therapies to restore hearing. Hearing loss affects 350m people in the world; 90% caused by sensorineural hearing loss (SNHL). There are currently no disease-modifying therapeutics for SNHL patients. Rinri's pioneering technology seeks to reverse SNHL through the regeneration of the damaged sensory cells in the inner ear, the cochlea. Rinri is backed by Boehringer Ingelheim Venture Fund (BIVF), UCB Ventures, BioCity and the University of Sheffield.
Location: United Kingdom, England, Sheffield
Employees: 1-10
Total raised: $15.756451M
Founded date: 2018
Investors 1
| Date | Name | Website |
| - | UCB Ventur... | ucbventure... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 22.04.2021 | - | $13.903622... | - |
| 20.05.2019 | Seed | $1.852829M | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 22.04.2021 | Rinri Therapeutics Raises £10M in Funding | Rinri Therapeutics, a Sheffield, England, UK-based biotechnology company developing a novel stem cel... | finsmes.co... |
| 22.05.2019 | UK-based biotech startup wants to treat hearing loss with th... | Rinri Therapeutics, a biotechnology company developing a novel cell-based therapy to restore hearing... | siliconcan... |
| 21.05.2019 | Term Sheet — Tuesday, May 21 | DEBUT DEAL Mary Meeker has made her first investment out of Bond Capital, the new firm she launched... | fortune.co... |
| 20.05.2019 | Rinri Therapeutics Raises £1.4M in Seed Funding | Rinri Therapeutics, a Sheffield, England, UK-based biotechnology company developing a novel cell-bas... | finsmes.co... |
| 20.05.2019 | Rinri Therapeutics raises €1.6 million seed to reverse heari... | Neuropathic sensorineural hearing loss (SNHL) is estimated to affect 64 million patients in the US, ... | eu-startup... |
| - | Rinri Therapeutics secures £1.4 million seed funding to adva... | 20 May 2019. Rinri Therapeutics, a biotechnology company developing a novel cell- based therapy to r... | ucbventure... |